产品中心 药物靶点和Fc受体 药物靶点

所有图片(1/1)

CLEC-1 Fc Chimera Protein, Human

C-type lectin domain family 1 member A,C-type lectin-like receptor 1

价格 3,840.00 1-2周
货号 UA010626
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 物种

    Human
  • 分子别名

    C-type lectin domain family 1 member A,C-type lectin-like receptor 1
  • Accession

    Q8NC01
  • 表达序列

    Gln74-Asp280, with N-terminal Human IgG Fc
  • 表达宿主

    HEK293
  • 分子量

    55-65kDa
  • 纯度

    >95% by SDS-PAGE
  • 内毒素含量

    <0.1EU/μg
  • 标记

    Unconjugated
  • 标签

    Human Fc
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4
  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.
  • 文献引用

    1.Sci Adv . 2022 Nov 16;8(46):eabo7621. Epub 2022 Nov 18.

背景介绍
  • CLEC-1 (C-type lectin-like receptor-1) is a type 2 transmembrane protein that belongs to the Dectin-1 family of C-type lectins. CLEC-1 is most highly expressed in activated dendritic cells and at lower levels in endothelial cells and monocytes. Dendritic cells (DCs) represent essential antigen-presenting cells that are critical for linking innate and adaptive immunity, and influencing T-cell responses. Studies have shown that CLEC-1 acts as an inhibitory receptor in dc, which can inhibit activation and downstream effect Th response. As a cell surface receptor, CLEC-1 may be a useful therapeutic target in the clinical regulation of t cell immune responses.

  • 电泳

    • 2μg (R: reducing conditions, N: non-reducing conditions).

评论(0)